Intellia Therapeutics NTLA Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Intellia Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:InvestmentsAndOtherNoncurrentAssets.
The official record: Intellia Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Intellia Therapeutics's other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Intellia Therapeutics's other non-current assets?
- Intellia Therapeutics (NTLA) reported other non-current assets of $38.01M in Q1 2026.
- How has Intellia Therapeutics's other non-current assets changed year-over-year?
- Intellia Therapeutics's other non-current assets decreased by 44.4% year-over-year, from $68.32M to $38.01M.
- What is the long-term trend for Intellia Therapeutics's other non-current assets?
- Over 5 years (2020 to 2025), Intellia Therapeutics's other non-current assets has grown at a 49.6% compound annual growth rate (CAGR), from $4.75M to $35.54M.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.